Persistent low carriage of serogroup A Neisseria meningitidistwo years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac

Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine

(2013) Paul A Kristiansen et al.   BMC INFECTIOUS DISEASES

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study

(2013) DM Daugla et al.   LANCET

Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt

(2013) Sara Tartof et al.   PLoS One

Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity

(2012) Paul A. Kristiansen, Fabien Diomandé, Absatou Ky Ba, Idrissa Sanou, Abdoul–Salam Ouédraogo, Rasmata Ouédraogo, Lassana Sangaré, Denis Kandolo, Flavien Aké, Inger Marie Saga, Thomas A. Clark, Lara Misegades, Stacey W. Martin, Jennifer Dolan Thomas, Sylvestre R. Tiendrebeogo, Musa Hassan-King, Mamoudou H. Djingarey, Nancy E. Messonnier, Marie-Pierre Préziosi, F. Marc LaForce, Dominique A. Caugant   CLINICAL INFECTIOUS DISEASES

Carriage of Neisseria lactamica in 1- to 29-Year-Old People in Burkina Faso: Epidemiology and Molecular Characterization

(2012) P. A. Kristiansen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data

(2012) Ryan T Novak et al.   LANCET INFECTIOUS DISEASES

Molecular Characterization of Invasive Meningococcal Isolates from Countries in the African Meningitis Belt before Introduction of a Serogroup A Conjugate Vaccine

(2012) Dominique A. Caugant et al.   PLoS One

Laboratory quality control in a multicentre meningococcal carriage study in Burkina Faso

(2012) Paul A. Kristiansen et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience

(2012) Mamoudou H. Djingarey et al.   VACCINE

Development of a group A meningococcal conjugate vaccine,MenAfriVacTM

(2012) Carl Frasch et al.   Human Vaccines & Immunotherapeutics

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine

(2011) Paul A. Kristiansen et al.   Clinical and Vaccine Immunology

Eliminating Epidemic Group A Meningococcal Meningitis In Africa Through A New Vaccine

(2011) F. Marc LaForce et al.   HEALTH AFFAIRS

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

(2011) Samba O. Sow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of a Pneumococcal Conjugate Vaccination Program on Carriage among Children in Norway

(2010) D. F. Vestrheim et al.   Clinical and Vaccine Immunology

Genetic Study of Capsular Switching between Neisseria meningitidis Sequence Type 7 Serogroup A and C Strains

(2010) Q. Wang et al.   INFECTION AND IMMUNITY

Evidence for Capsule Switching between Carried and Disease-Causing Neisseria meningitidis Strains

(2009) A. J. Beddek et al.   INFECTION AND IMMUNITY

Global epidemiology of meningococcal disease

(2009) Lee H. Harrison et al.   VACCINE

Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002–2006

(2008) M. J. SIMÕES et al.   EPIDEMIOLOGY AND INFECTION

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

(2008) Martin C. J. Maiden et al.   JOURNAL OF INFECTIOUS DISEASES